APON(SZ:300753) Sou Hu Cai Jing·2025-06-05 09:34Company Overview - Aipeng Medical focuses on the research, production, and sales of medical devices in pain management and nasal cavity management [1] - The company's main products include pain management products and nasal cavity management products [1] Financial Performance - For Q1 2025, Aipeng Medical reported revenue of 64.82 million yuan, a year-on-year decrease of 26.13% [1] - The net profit for the same period was -17.65 million yuan, reflecting a year-on-year decline of 1400.65% [1] - The gross profit margin stood at 61.91% [1] Market Position - Aipeng Medical's "Nose Clear" nasal care products have been the top-selling items in the nasal irrigation category on both Tmall and JD.com for nine consecutive years [1] - The brand has received several awards, including the "West Lake Award for Innovative Marketing" and recognition as a "Star Product Most Popular Among Pharmacies" [1] - "Nose Clear" has been included in the Shanghai Key Trademark Protection List, highlighting its market significance [1] Shareholder Information - As of March 31, 2025, Aipeng Medical had 20,629 shareholders, an increase of 1,752 from the previous count [1] - The average market value of shares held by each shareholder is 352,800 yuan, with an average holding of 27,600 shares [1] Valuation Metrics - Aipeng Medical's current price-to-earnings (PE) ratio (TTM) is -382.20, and the price-to-book (PB) ratio is 4.60 [2] - The total market capitalization of Aipeng Medical is 3.136 billion yuan [2]